GEN-009

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameGEN-009
Drug Alias NameGEN-009
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT-cell surface antigen CD4 inhibitorsCluster of differentiation 8 inhibitors
TargetsT-cell surface antigen CD4Cluster of differentiation 8
Therapy Area/IndicationsSkin MelanomaCarcinoma, Non-Small-Cell LungCarcinoma, Transitional Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenocea Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenocea Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSkin MelanomaCarcinoma, Non-Small-Cell LungCarcinoma, Transitional Cell +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A